Sepsis Market Research Report Information By Type (Diagnosis, and Therapeutics), By Product (Reagents, Assay, Instruments, and Software) By Technology (Microbiology, PCR, Sequencing, and Biomarkers), By Test Type (Lab, and POC), By Pathogen (Bacterial, Viral, and Fungal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By End User (Hospitals, and Pathology and Reference Laboratories), By Application (Sepsis, Severe Sepsis, and Septic Shock), And By Region (North America, Europe, Asia-Pacific, And Res

Global Sepsis Market Overview

Sepsis Market Size was valued at USD 0.51 Billion in 2022. The sepsis industry is projected to grow from USD 0.6 Billion in 2023 to USD 1.2 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.90 % during the forecast period (2024 - 2032). Growing Investments and Progress with a Growing Burden of Infectious Diseases are the key market drivers augmenting the growth of the industry.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Sepsis Market Trends

• Increasing advancements and investments is driving the market growth

Market CAGR for sepsis is being driven by the Increasing Advancements and Investments. A compromised immune system can lead to sepsis, a hazardous condition that exposes patients to bacterial, viral, fungal, parasitic, and other infections. It's among the main reasons why people die in hospitals. Sepsis arises from the immune system of the host reacting to an infection by producing chemicals to treat the illness.

Additionally, The market is expected to be cushioned by an increase in funding for research linked to sepsis as well as increased investments in intensive research and development activities, such as novel blood culture techniques for diagnosing and treating chronic infections. Furthermore, the market is expected to see significant growth due to the technical advancements in the field of molecular diagnostics as well as the growing demand for fast and precise findings. The development of new immunological and molecular biomarkers that allow for the early diagnosis of sepsis as a result of numerous technological breakthroughs is expected to accelerate the growth rate of the sepsis market in the future.

The primary driver of growth in this market is the increasing prevalence of infectious infections, which in turn causes an increase in sepsis cases. The market is anticipated to develop at a faster rate overall because to an increase in hospital-acquired infections (HAIs), including sepsis, pneumonia, and urinary tract infections. It is also anticipated that the market would develop due to the growing healthcare industry and the rising use of sophisticated data analytics technologies. Additionally, the market's growth is anticipated to be restrained during the projected period by doctors' and patients' growing awareness of hospital-acquired infections and chronic conditions.

For instance, According to a 2020 report by the  Sepsis Alliance, the condition is thought to be the cause of 11 million fatalities ly year, more than the sum of deaths from HIV/AIDS, prostate cancer, and breast cancer put together. Thus, result in driving the sepsis market revenue.

Sepsis Market Segment Insights

Sepsis Type Insights

The  sepsis market segmentation, based on type includes Diagnosis, and Therapeutics. The therapeutics segment dominated the market. Treatments are necessary to manage and eradicate the fundamental cause of illness, which is frequently fungal, bacterial, or viral in origin. Rapid and focused antimicrobial treatment is essential to fight the infection and stop sepsis from getting worse.

Sepsis Product Insights                            

The  sepsis market segmentation, based on Product, includes Reagents, Assay, Instruments, and Software. The assay category generated the most income. This is because Assay kits with various analyzers offer high-throughput analytical results for the diagnosis of illness.

Sepsis Technology Insights                              

The  sepsis market segmentation, based on Technology includes Microbiology, PCR, Sequencing, and Biomarkers. The microbiology segment dominated the market. The main and most effective technique for identifying organisms that cause infectious diseases in lab settings is microbial culture. Furthermore, in the near future, new strategic initiatives by major competitors will further propel the segment's growth.

Sepsis Test Type Insights                          

The  sepsis market segmentation, based on Test Type, includes Lab, and POC. The lab category generated the most income. Improvements in laboratory testing have facilitated a quicker and more accurate diagnosis of sepsis, improving patient outcomes. These tests detect whether an infection is present in the body by using biomarkers like procalcitonin or cytokines.

Sepsis Pathogen Insights

The  sepsis market segmentation, based on Pathogen includes Bacterial, Viral, and Fungal. The bacterial segment dominated the market. Due to the increase in bacterial sepsis cases, hospital-transmitted illnesses, and surgical operations performed, it is predicted to lead during the projected period.

Sepsis Distribution channel Insights       

The  sepsis market segmentation, based on distribution channel, includes Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. The hospital pharmacies category generated the most income, due to a rise in hospital admissions. It is projected that a number of ongoing improvements to improve diagnostic testing will strengthen the segment.

Sepsis End User Insights

The  sepsis market segmentation, based on End User includes Hospitals, and Pathology and Reference Laboratories. The hospitals segment dominated the market, because these patients' intensive care unit (ICU) treatments are so severe. As a result, the majority of symptomatic testing is restricted to medical clinics. It is anticipated that this variable will advance this segment's development.

Sepsis Application Insights                      

The  sepsis market segmentation, based on Application, includes Sepsis, Severe Sepsis, and Septic Shock. The sepsis category generated the most income. Appropriate and fast diagnosis of sepsis is essential for effective treatment. Early diagnosis and treatment initiation are facilitated by diagnostic instruments and assays that detect infections or biomarkers linked to sepsis.

Figure1: Sepsis Market, by Application, 2022&2032(USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Sepsis Regional Insights

By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American sepsis market area will dominate this market. The reason why North America leads the world market for sepsis is due to the region's rising per capita healthcare spending, strong demand for better healthcare facilities, expanding use of cutting-edge diagnostic techniques, and rising rates of chronic illnesses like diabetes and cancer that can result in sepsis.

Further, the major countries studied in the market report are The US, German, France, the UK, Canada, Italy, Spain, India, Australia, South Korea, China, Japan, and Brazil.

Figure2: SEPSIS MARKET SHARE BY REGION 2022 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe sepsis market has the second-largest portion of the market, due to growing costs associated with research and development, an aging population, and unsanitary conditions in many developing nations. Further, the German sepsis market had the biggest market share, and the UK sepsis market was the European market with the quickest rate of growth.

The Asia-Pacific Sepsis Market is anticipated to expand between 2023 and 2032 at the quickest CAGR. This is because of the large number of elderly people, the rising rates of diabetes and cancer in nations like Australia, China, and India, as well as the region's expanding healthcare system. Moreover, China’s sepsis market had the biggest market share, and the Indian sepsis market was the Asia-Pacific region's fastest-growing market.

Sepsis Key Market Players& Competitive Insights

Leading market players are putting a lot of money into R&D to expand their product lines, which will help the sepsis market, keep growing. Additionally, market players are engaging in a range of calculated initiatives to increase their worldwide presence, with important market developments involving the introduction of new products, contracts, M&A transactions, increased investment, and cooperation with other enterprises. To grow and endure in an increasingly cutthroat and dynamic market, sepsis industry must provide reasonably priced goods.

Manufacturing locally is one of the primary business techniques used by manufacturers to cut operational costs in the  sepsis industry to help customers and expand the market segment. In recent years, the sepsis industry has provided some of the biggest benefits to medicine. Major players in the sepsis market, including bioMérieux (France), BD (US), Danaher (US), Biosystems Inc., (US),  Luminex Corporation (US),  F. Hoffmann-La Roche Ltd., (Switzerland), Thermo Fisher Scientific Inc., (US), and others, are engaging in research and development activities in an effort to boost market demand.

bioMérieux is focused on in vitro diagnostics. Located in Marcy-l'Étoile, France, the company was founded in 1963 by Alain Mérieux. In order to address the  healthcare issues associated with infectious diseases, bioMérieux has developed a development plan that is based on an international and long-term vision. Clinical microbiology, immunoassays, molecular biology, and other fields are among the many diagnostic solutions provided by the company. With almost 13,000 employees ly, bioMérieux reported €3.4 billion in revenue in 2021.

Danaher Corporation is a multinational conglomerate based in the United States that creates, manufactures, and promotes products and services for the professional, medical, industrial, and commercial industries. The company's headquarters are in Washington, D.C., in the United States. Steven M. Rales and Mitchell P. Rales started it in 1969. Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions are the four business segments that make up Danaher. Healthcare, life sciences, research, and industrial markets are just a few of the areas that make use of the company's goods and services. Danaher reported $22.3 billion in revenue in 2020 and employed more than 69,000 people ly.

Key Companies in the sepsis market include

• bioMérieux (France)


• BD (US)


• Danaher (US)


• Biosystems Inc., (US),


• Luminex Corporation (US)


• Hoffmann-La Roche Ltd., (Switzerland)


• Thermo Fisher Scientific Inc., (US)


• Bruker (US)


• Abbott (US),


• Immunexpress Inc. (U.S)


• Axis-Shield Diagnostics Ltd. UK)


• Quidel Corporation (US)


• Siemens (Germany)


• EKF Diagnostics (UK)


• Seegene Inc., (South Korea)


• Boditech Med Inc., (South Korea),


• Alifax S.r.l. (Italy)

Sepsis Industry Developments

January 2021: BARDA has chosen the clinical research division of Biosystems Inc. to assist with a phase II platform clinical trial aimed at treating acute respiratory distress syndrome (ARDS).

October 2021: Luminex Corporation declared that it has partnered with Boehringer Ingelheim on a companion diagnostic agreement to identify NSCLC patients who will get tailored therapy.

In 2019: Hoffmann-La Roche Ltd. introduced two novel medications: Actemra/RoActemra, a treatment for severe COVID-19, and Gavreto, a treatment for a particular kind of advanced lung cancer.

Sepsis Market Segmentation

Sepsis Type Outlook

• Diagnosis


• Therapeutics

Sepsis Product Outlook

• Reagents


• Assay


• Instruments


• Software

Sepsis Technology Outlook

• Microbiology


• PCR


• Sequencing


• Biomarkers

Sepsis Test Type Outlook

• Lab


• POC

Sepsis Pathogen Outlook

• Bacterial


• Viral


• Fungal

Sepsis Distribution Channel Outlook

• Hospital Pharmacies


• Retail Pharmacies


• Online Pharmacies

Sepsis End User Outlook

• Hospitals


• Pathology and Reference Laboratories

Sepsis Application Outlook

• Sepsis


• Severe Sepsis


• Septic Shock

Sepsis Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America